03:20:00 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-14 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-08-14 Extra Bolagsstämma 2024
2024-05-29 X-dag ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 Årsstämma 2024
2024-05-15 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 X-dag ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 Årsstämma 2023
2023-05-11 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 X-dag ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 Årsstämma 2022
2022-05-24 Kvartalsrapport 2022-Q1
2022-03-02 Bokslutskommuniké 2021
2021-11-25 Kvartalsrapport 2021-Q3
2021-08-26 Kvartalsrapport 2021-Q2
2021-06-17 X-dag ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 Årsstämma 2021
2021-05-27 Kvartalsrapport 2021-Q1
2021-03-02 Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2024-07-23 14:30:00
Oslo, Norway - 23 July 2024 - Circa Group AS will be holding an extraordinary
general meeting on 14 August 2024 at 09:00 CET. The Company's shares are today
traded at around or below the same price as the nominal value. In order to
enable a capital raising process and give the board of directors the necessary
flexibility, it is proposed that the nominal value of the shares is reduced and
that board authorisations are updated accordingly.

The board of Circa Group AS has approved the final agenda for the extraordinary
general meeting:

1. Election of a person to chair the general meeting
2. Election of a person to co-sign the minutes
3. Approval of the notice and agenda
4. Share capital reduction
5. Board authorisation to increase the share capital by issuance of
new shares
6. Board authorisation to take up loan giving the right to demand
the issuance of shares (convertible loan)

The extraordinary general meeting will be held as a virtual meeting at
https://dnb.lumiagm.com/151996834. The notice, weblink and voting form for the
extraordinary general meeting will be made available at www.circa-group.com. The
notice and voting form for the extraordinary general meeting will be sent to all
shareholders with known address today.

To participate in the general meeting, please log in to: https://web.lumiagm.com
either on your smartphone, tablet or PC. Enter Meeting ID: 151-996-834 and join
the meeting. You must then identify yourself with the reference number and PIN
code from VPS for the general meeting, which you will find in VPS Investor
Services (Corporate Actions - General Meeting - ISIN). Shareholders who have not
elected electronic notices in VPS will receive the reference number and PIN code
on the forms enclosed to the notice distributed by post. Shareholders can log in
to the general meeting up to one hour before the meeting starts, i.e. from 08:00
CET. Shareholders must be logged in before the general meeting starts to be able
to vote. Shareholders are welcome to contact DNB Registrars Department on phone
+ 47 23 26 80 20 (between 08:00-15:30 CET) or send an e-mail to genf@dnb.no if
they need their reference number and PIN code or if they have technical
questions.

PLEASE NOTE THAT SHAREHOLDERS WISHING TO PARTICIPATE AT THE VIRTUAL
EXTRAORDINARY GENERAL MEETING MAY CHOOSE TO VOTE IN ADVANCE OR BY PROXY, AS
FURTHER DESCRIBED IN THE NOTICE FOR THE EXTRAORDINARY GENERAL MEETING.

Deadline for registration of advance votes and proxies is 13 August 2024 at
12:00 CET.

Please find attached the following documents:
o Notice for the Extraordinary General Meeting 14 August 2024
o Power of Attorney and registration form - English
o Fullmakts og påmeldingsskjema - Norwegian

All documents to be processed in the meeting are also available on our web site
www.circa-group.com/investors/reports-presentations.


About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM, an alternative to traditional polar aprotic solvents. By
creating renewable chemicals from cellulose, Circa is extracting value from
non-food, biomass and addressing a gap in the market by providing bio-based
alternatives contributing to a more circular economy. Circa's ambition is to be
Changing Chemistry for GoodTM.
www.circa-group.com


Investor Contact Circa Group

Erik Berger
Chief Financial Officer
Circa Group AS
Erik.berger@circa-group.com
Tel: +47 908 55 033